Chengwei Capital is a venture capital firm that primarily focuses on early-stage investments in technology and innovative sectors within China. The firm emphasizes long-term partnerships and provides strategic support to foster growth in high-potential ventures across diverse industries such as AI, biotechnology, renewable energy, mobility, enterprise applications, and advanced manufacturing.
50% of their portfolio is in Healthcare. They made 1 investments in the last 12 months. Their most common stage is series-b (50% of deals). Average disclosed round size is $62.5M (across 7 rounds with reported amounts).
Portfolio
8
Fund Size
$1.5B
Top Stage
Series B
Last 12 Mo
1
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
8 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Full-Life Technologies | Series C | $77M | Sep 2025 |
| Full-Life Technologies | Series B | $47.3M | Jan 2024 |
 Sensely | Series A | $15M | Oct 2019 |
 Sila Nanotechnologies | Growth | $170M | Apr 2019 |
| SSense.ly | Series B | $8M | Feb 2017 |
 APUS Group | Series B | $100M | Jan 2015 |
 Light Chaser Animation Studios | Series B | $20M | Jun 2014 |
| SStarfive Technology | Seed | — | — |
Top Co-Investors
Prosperity7 Ventures2 shared
Summer Capital2 shared
Junson Capital2 shared
Baidu Venture1 shared
Susquehanna1 shared
Sojitz Corporation1 shared
Silicon Valley Bank1 shared
Mojo Partners1 shared
Pegasus Tech Ventures1 shared
Redpoint Ventures1 shared
SIG1 shared
Northern Light Venture Capital1 shared
8VC1 shared
Bessemer Venture Partners1 shared
Matrix Partners1 shared
Daimler1 shared
Siemens' Next471 shared
Sutter Hill Ventures1 shared
GGV Capital1 shared
Sky9 Capital1 shared
Last updated: 16 April 2026